Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.

Ye L, Chan FL, Chen S, Leung LK.

J Nutr Biochem. 2012 Oct;23(10):1230-7. doi: 10.1016/j.jnutbio.2011.07.003. Epub 2011 Dec 30.

PMID:
22209285
2.

The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.

Li F, Chow S, Cheung WH, Chan FL, Chen S, Leung LK.

J Nutr Biochem. 2013 Jun;24(6):1112-6. doi: 10.1016/j.jnutbio.2012.08.010. Epub 2012 Dec 11.

PMID:
23238426
3.
4.

Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice.

Wong TY, Li F, Lin SM, Chan FL, Chen S, Leung LK.

BMC Cancer. 2014 Jun 12;14:426. doi: 10.1186/1471-2407-14-426.

5.

A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.

Foster PA, Chander SK, Newman SP, Woo LW, Sutcliffe OB, Bubert C, Zhou D, Chen S, Potter BV, Reed MJ, Purohit A.

Clin Cancer Res. 2008 Oct 15;14(20):6469-77. doi: 10.1158/1078-0432.CCR-08-1027.

6.

Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo.

Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG.

Carcinogenesis. 2008 Nov;29(11):2162-8. doi: 10.1093/carcin/bgn161. Epub 2008 Jul 16.

7.

Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.

Li F, Ye L, Lin SM, Leung LK.

Mol Cell Endocrinol. 2011 Sep 15;344(1-2):51-8. doi: 10.1016/j.mce.2011.06.024. Epub 2011 Jun 30.

PMID:
21741436
8.

Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.

Ye L, Gho WM, Chan FL, Chen S, Leung LK.

Int J Cancer. 2009 Mar 1;124(5):1028-36. doi: 10.1002/ijc.24046. Erratum in: Int J Cancer. 2009 Oct 15;125(8):1995.

9.

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Thiantanawat A, Long BJ, Brodie AM.

Cancer Res. 2003 Nov 15;63(22):8037-50.

10.

Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.

Nukatsuka M, Saito H, Nakagawa F, Abe M, Uchida J, Shibata J, Matsuo K, Noguchi S, Kiniwa M.

Breast Cancer Res Treat. 2011 Jul;128(2):381-90. doi: 10.1007/s10549-010-1141-3. Epub 2010 Aug 31.

PMID:
20809360
11.
12.
13.
14.

Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.

Zhou N, Han SY, Zhou F, Li PP.

J Ethnopharmacol. 2014 Jul 3;154(3):687-95. doi: 10.1016/j.jep.2014.04.045. Epub 2014 May 6.

PMID:
24809288
15.
17.

Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.

Kijima I, Phung S, Hur G, Kwok SL, Chen S.

Cancer Res. 2006 Jun 1;66(11):5960-7.

18.

Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

Sonne-Hansen K, Lykkesfeldt AE.

J Steroid Biochem Mol Biol. 2005 Jan;93(1):25-34. Epub 2005 Jan 27.

PMID:
15748829
19.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
20.

Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells.

Kim J, Jayaprakasha GK, Patil BS.

Food Funct. 2013 Feb;4(2):258-65. doi: 10.1039/c2fo30209h.

PMID:
23117440

Supplemental Content

Support Center